Author:
Naidoo Inbarani,Roper Cally
Subject
Infectious Diseases,Parasitology
Reference66 articles.
1. World Health Organisation Policy Recommendation on Intermittent Preventive Treatment during Infancy with Sulphadoxine-Pyrimethamine (SP-IPTi) for Plasmodium falciparum Malaria Control in Africa;World Health and Organisation,2010
2. World Health Organisation Policy Recommendation: Seasonal Malaria Chemoprevention (SMC) for Plasmodium falciparum Malaria Control in Highly Seasonal Transmission Areas of the Sahel sub-region in Africa;World Health and Organisation,2012
3. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria;Peterson;Proc. Natl. Acad. Sci. U.S.A.,1988
4. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum;Cowman;Proc. Natl. Acad. Sci. U.S.A.,1988
5. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine;Brooks;Eur. J. Biochem.,1994